切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2016, Vol. 02 ›› Issue (04) : 263 -265. doi: 10.3877/cma.j.issn.2096-1537.2016.04.008

所属专题: 重症医学 文献

观点

急性呼吸窘迫综合征:我选择高流量氧疗
刘玲1,()   
  1. 1. 210009 南京,东南大学附属中大医院重症医学科
  • 收稿日期:2016-10-27 出版日期:2016-11-28
  • 通信作者: 刘玲
  • 基金资助:
    江苏省临床医学科技专项(BL2013030)

To treat acute respiratory distress syndrome: I prefer high-flow nasal cannula oxygen therapy

Ling Liu1,()   

  1. 1. Department of Critical Care Medicine, Zhongda Hospital, Southeast University, Nanjing 210009, China
  • Received:2016-10-27 Published:2016-11-28
  • Corresponding author: Ling Liu
  • About author:
    Corresponding author: Liu Ling, Email:
引用本文:

刘玲. 急性呼吸窘迫综合征:我选择高流量氧疗[J]. 中华重症医学电子杂志, 2016, 02(04): 263-265.

Ling Liu. To treat acute respiratory distress syndrome: I prefer high-flow nasal cannula oxygen therapy[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2016, 02(04): 263-265.

急性呼吸窘迫综合征(acute respiratory distress syndrome, ARDS)是急性低氧性呼吸衰竭最常见的原因,肺内分流导致的顽固低氧血症是ARDS最突出的临床表现。由于经鼻高流量氧疗(high-flow nasal cannula,HFNC)可增加呼吸末正压及呼气末肺容积,且具有无创和舒适度高等优势,已逐渐成为部分轻、中度ARDS患者一线的氧疗措施。

Acute respiratory distress syndrome (ARDS) is the most common cause of acute hypoxemic respiratory failure. Refractory hypoxemia due to intra-pulmonary shunt is the most prominent clinical manifestation of ARDS. With the therapeutic advantages of increasing positive end expiratory pressure, end-expiratory lung volume and patient comfort, high-flow nasal cannula oxygen therapy (HFNC) has been widely applied as the first-line oxygen therapy strategy in mild and moderate ARDS patients.

[1]
Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries[J]. JAMA, 2016, 315(8): 788-800.
[2]
Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure[J]. N Engl J Med, 2015, 372(23): 2185-2196.
[3]
Groves N, Tobin A. High flow nasal oxygen generates positive airway pressure in adult volunteers[J]. Aust Crit Care, 2007, 20(4): 126-131.
[4]
Chikata Y, Izawa M, Okuda N, et al. Humidification performance of two high-flow nasal cannula devices: a bench study[J]. Respir Care, 2014, 59(8): 1186-1190.
[5]
Leite MR, Ramos EM, Kalva-Filho CA, et al. Effects of 12 weeks of aerobic training on autonomic modulation, mucociliary clearance, and aerobic parameters in patients with COPD[J]. Int J Chron Obstruct Pulmon Dis, 2015, 10(1): 2549-2557.
[6]
Spoletini G, Alotaibi M, Blasi F, et al. Heated humidified high-flow nasal oxygen in adults mechanisms of action and clinical implications[J]. Chest, 2015, 148(1): 253-261.
[7]
Nagata K, Morimoto T, Fujimoto D, et al. Efficacy of high-flow nasal cannula therapy in acute hypoxemic respiratory failure: decreased use of mechanical ventilation[J]. Respir Care, 2015, 60(10): 1390-1396.
[8]
Messika J, Ben Ahmed K, Gaudry S, et al. Use of high-flow nasal cannula oxygen therapy in subjects with ARDS: A 1-year observational study[J]. Respir Care, 2015, 60(2): 162-169.
[9]
Frat JP, Brugiere B, Ragot S, et al. Sequential application of oxygen therapy via high-flow nasal cannula and noninvasive ventilation in acute respiratory failure: An observational pilot study[J]. Respir Care, 2015, 60(2): 170-178.
[10]
Stephan F, Barrucand B, Petit P, et al. High-flow nasal oxygen vs noninvasive positive airway pressure in hypoxemic patients after cardiothoracic surgery: a randomized clinical trial[J]. JAMA, 2015, 313(23): 2331-2333.
[11]
Hernández G, Vaquero C, Colinas L, et al. Effect of postextubation high-flow nasal cannula vs noninvasive ventilation on reintubation and postextubation respiratory failure in high-risk patients. A randomized clinical trial[J]. JAMA, 2016, 315(13).
[12]
Slutsky AS, Ranieri VM. Ventilatorinduced lung injury[J]. N Engl J Med, 2013, 369(22): 2126-2136
[13]
De Prost N, Ricard JD, Saumon G, Dreyfuss D. Ventilator-induced lung injury: historical perspectives and clinical implications[J]. Ann Intensive Care, 2011, 1(1): 28.
[14]
Thille AW, Contou D, Fragnoli C, et al. Non-invasive ventilation for acute hypoxemic respiratory failure: intubation rate and risk factors[J]. Critical Care, 2013, 17(6): R269.
[15]
Ferrer M, Torres A. Noninvasive ventilation for acute respiratory failure[J]. Curr Opin Crit Care, 2015, 21(1): 1-6.
[16]
Carrillo A, Gonzalez-Diaz G, Ferrer M, et al. Non-invasive ventilation in community-acquired pneumonia and severe acute respiratory failure[J]. Intensive Care Med, 2012, 38(3): 458-466.
[17]
Esteban A, Frutos-Vivar F, Ferguson ND, et al. Noninvasive positive-pressure ventilation for respiratory failure after extubation[J]. N Engl J Med, 2004, 350(24): 2452-2460.
[18]
Jeong JH, Kim DH, Kim SC, et al. Changes in arterial blood gases after use of high-flow nasal cannula therapy in the ED[J]. Am J Emerg Med, 2015, 33(10): 1344-1349.
[1] 许振琦, 易伟, 范闻轩, 王金锋. 经鼻高流量氧疗与无创机械通气在严重创伤术后轻中度低氧血症患者中的临床应用[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 306-309.
[2] 吕莉, 乔莉娜. 经鼻高流量氧疗治疗重症肺炎患儿的疗效[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(01): 38-45.
[3] 汪俊谷, 潘华琴, 杨雨田. HFNC治疗急性低氧性呼吸衰竭插管预后及影响因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 523-525.
[4] 饶林静, 罗皓梨, 钟山. 不同时长PPV在体外循环心脏大血管术后并发ARDS中的临床应用[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 575-577.
[5] 罗婷, 张实. 5种生物标志物对ARDS预后的预测分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 471-475.
[6] 李伟, 卓剑, 黄川, 黄有攀. Lac、HO-1、sRAGE、CRP/ALB表达及脓毒症并发ARDS危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 514-516.
[7] 胡宗俊, 陈建国, 黄霞. ARDS机械通气继发肺栓塞危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 388-390.
[8] 张松涛, 李世金, 凌霄, 吴文辉. 胸部物理治疗联合布地奈德雾化对多发伤患者并发ARDS的临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 373-375.
[9] 宣瑞萍, 刘笑琴, 王平, 查日田. 无创正压通气与经鼻高流量氧疗治疗AECOPD合并Ⅱ型呼吸衰竭的临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 346-348.
[10] 杨智晖, 赵宇博, 许倩, 潘洁, 常兴芳, 路康, 许宁. 经鼻高流量湿化氧疗治疗支气管扩张症伴感染临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 206-208.
[11] 谭林, 蒲运刚, 朱顺, 杨希. 急性呼吸窘迫综合征患者血清FGF21、ANGPTL4、HO-1表达及其临床意义[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 227-229.
[12] 陈蕊, 杨洪娜, 方巍, 李鑫鑫, 李甜甜, 于孝义, 王艳雪, 李文玉. 血清与支气管肺泡灌洗液中细胞因子水平与肺内外ARDS的相关性研究[J]. 中华重症医学电子杂志, 2023, 09(03): 251-258.
[13] 吴梅清, 林瑾, 段美丽, 薛晓艳. 高密度脂蛋白水平对脓毒症相关的ARDS发生的影响[J]. 中华重症医学电子杂志, 2023, 09(02): 191-197.
[14] 陈栋玉, 潘纯, 杨毅. ARDS患者自主呼吸努力评估方法的研究进展[J]. 中华重症医学电子杂志, 2023, 09(01): 84-88.
[15] 王洁琼, 王慧霞, 赵慧颖, 安友仲. 血管紧张素转换酶2对人肺微血管内皮细胞炎性损伤的调控作用[J]. 中华重症医学电子杂志, 2023, 09(01): 78-83.
阅读次数
全文


摘要